NDA Panel2022ON-7203

Safety of the extension of use of galacto‐oligosaccharides (GOS) as a novel food in food for special medical purposes pursuant to Regulation (EU) 2015/2283

ApplicantGLNP Life Sciences B.V.
SubstanceGalacto-oligosaccharides
QuestionEFSA-Q-2020-00747
DOI10.2903/j.efsa.2022.7203
DossierNF 2020/1606